A new study in Current Pharmaceutical Analysis highlights the potential of essential oil compounds derived from the ...
On RemeGen (688331.SH/09995.HK) announced that the results of the Phase III clinical study of Telitacicept for Sjögren's Syndrome in China have been published in an abstract on the 2025 ACR website.
Smokefree India today issued a four-point call to action ahead of COP11 of the WHO Framework Convention on Tobacco Control (FCTC), urging delegates to confront India's escalating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback